Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial

Stocks | Futures | Watchlist | More
or

Tango Therapeutics Inc (TNGX)

Tango Therapeutics Inc (TNGX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 559,924
  • Shares Outstanding, K 88,177
  • Annual Sales, $ 37,040 K
  • Annual Income, $ -58,240 K
  • 60-Month Beta 1.66
  • Price/Sales 23.11
  • Price/Cash Flow N/A
  • Price/Book 2.10
Trade TNGX with:

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 3 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/22
See More
  • Average Estimate -0.36
  • Number of Estimates 3
  • High Estimate -0.35
  • Low Estimate -0.37
  • Prior Year -0.25
  • Growth Rate Est. (year over year) -44.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
5.80 +5.86%
on 02/08/23
8.40 -26.90%
on 01/12/23
-1.63 (-20.98%)
since 01/06/23
3-Month
5.80 +5.86%
on 02/08/23
8.49 -27.68%
on 11/15/22
-1.60 (-20.67%)
since 11/08/22
52-Week
3.18 +93.08%
on 09/22/22
9.99 -38.54%
on 02/14/22
-2.86 (-31.78%)
since 02/08/22

Most Recent Stories

More News
Tango Therapeutics, Inc. (TNGX) Reports Q3 Loss, Tops Revenue Estimates

Tango Therapeutics, Inc. (TNGX) delivered earnings and revenue surprises of -3.13% and 15.99%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?...

TNGX : 6.14 (-3.31%)
IMTX : 8.58 (-1.83%)
Cara Therapeutics (CARA) Reports Q3 Loss, Tops Revenue Estimates

Cara (CARA) delivered earnings and revenue surprises of -2.38% and 28.91%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

CARA : 11.67 (-2.26%)
TNGX : 6.14 (-3.31%)
Denali Therapeutics Inc. (DNLI) Reports Q3 Loss, Lags Revenue Estimates

Denali Therapeutics Inc. (DNLI) delivered earnings and revenue surprises of -1.20% and 64.61%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?...

DNLI : 30.49 (-4.60%)
TNGX : 6.14 (-3.31%)
Tango Therapeutics, Inc. (TNGX) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release

Tango Therapeutics, Inc. (TNGX) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

TNGX : 6.14 (-3.31%)
AMGN : 240.20 (-1.56%)
Why Tango Therapeutics Shares Rose 39.7% This Week

The clinical-stage biotech company has two candidates in its drug pipeline.

TNGX : 6.14 (-3.31%)
Tango Therapeutics, Inc. (TNGX) Stock Jumps 16.3%: Will It Continue to Soar?

Tango Therapeutics, Inc. (TNGX) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the...

TNGX : 6.14 (-3.31%)
MYOV : 26.89 (-0.07%)
Can Tango Therapeutics, Inc. (TNGX) Climb 219% to Reach the Level Wall Street Analysts Expect?

The average of price targets set by Wall Street analysts indicates a potential upside of 219.4% in Tango Therapeutics, Inc. (TNGX). While the effectiveness of this highly sought-after metric is questionable,...

TNGX : 6.14 (-3.31%)
Tango Therapeutics Reports Second Quarter 2022 Financial Results and Provides Business Highlights

– Patients with MTAP-deleted solid tumors being actively enrolled in ongoing Phase 1/2 trial of TNG908, an MTA-cooperative PRMT5 inhibitor – – Received...

TNGX : 6.14 (-3.31%)
Tango Therapeutics Added to Russell 2000®, 3000® and Microcap® Indexes

CAMBRIDGE, Mass., June 27, 2022 (GLOBE NEWSWIRE) -- Tango Therapeutics, Inc. (NASDAQ: TNGX), a biotechnology company committed to discovering and...

TNGX : 6.14 (-3.31%)
Tango Therapeutics Added to Russell 2000®, 3000® and Microcap® Indexes

CAMBRIDGE, Mass., June 27, 2022 (GLOBE NEWSWIRE) -- Tango Therapeutics, Inc. (NASDAQ: TNGX), a biotechnology company committed to discovering and...

TNGX : 6.14 (-3.31%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Buy with a Weakening short term outlook on maintaining the current direction.

See More Share

Business Summary

Tango Therapeutics Inc. is a biotechnology company. It focused on discovering and delivering precision cancer medicines. Tango Therapeutics Inc., formerly known as BCTG Acquisition Corp., is based in CAMBRIDGE, Mass.

See More

Key Turning Points

3rd Resistance Point 7.18
2nd Resistance Point 6.83
1st Resistance Point 6.49
Last Price 6.14
1st Support Level 5.80
2nd Support Level 5.45
3rd Support Level 5.11

See More

52-Week High 9.99
Fibonacci 61.8% 7.39
Fibonacci 50% 6.59
Last Price 6.14
Fibonacci 38.2% 5.78
52-Week Low 3.18

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar